ACM
Argent Capital Management’s Biogen BIIB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-4,262
| Closed | -$1.48M | – | 182 |
|
|
2021
Q2 | $1.48M | Sell |
4,262
-46,908
| -92% | -$16.2M | 0.05% | 105 |
|
|
2021
Q1 | $14.3M | Buy |
51,170
+15,760
| +45% | +$4.41M | 0.48% | 54 |
|
|
2020
Q4 | $8.67M | Sell |
35,410
-62,150
| -64% | -$15.2M | 0.31% | 59 |
|
|
2020
Q3 | $27.7M | Sell |
97,560
-2,024
| -2% | -$574K | 1.06% | 30 |
|
|
2020
Q2 | $26.6M | Sell |
99,584
-11,010
| -10% | -$2.95M | 1.11% | 31 |
|
|
2020
Q1 | $35M | Buy |
110,594
+548
| +0.5% | +$173K | 1.65% | 22 |
|
|
2019
Q4 | $32.7M | Sell |
110,046
-3,968
| -3% | -$1.18M | 1.12% | 32 |
|
|
2019
Q3 | $26.5M | Buy |
114,014
+548
| +0.5% | +$128K | 0.99% | 32 |
|
|
2019
Q2 | $26.5M | Sell |
113,466
-9,541
| -8% | -$2.23M | 1.01% | 32 |
|
|
2019
Q1 | $29.1M | Buy |
123,007
+35,853
| +41% | +$8.47M | 1.06% | 31 |
|
|
2018
Q4 | $26.2M | Sell |
87,154
-43,636
| -33% | -$13.1M | 1.32% | 23 |
|
|
2018
Q3 | $46.2M | Buy |
130,790
+2,968
| +2% | +$1.05M | 1.58% | 28 |
|
|
2018
Q2 | $37.1M | Sell |
127,822
-3,405
| -3% | -$988K | 1.34% | 30 |
|
|
2018
Q1 | $35.9M | Sell |
131,227
-1,280
| -1% | -$350K | 1.31% | 30 |
|
|
2017
Q4 | $46.1M | Buy |
132,507
+1,035
| +0.8% | +$360K | 1.59% | 24 |
|
|
2017
Q3 | $41.2M | Buy |
+131,472
| New | +$41.2M | 1.59% | 24 |
|
|
2014
Q3 | – | Sell |
-5,224
| Closed | -$1.65M | – | 161 |
|
|
2014
Q2 | $1.65M | Hold |
5,224
| – | – | 0.09% | 112 |
|
|
2014
Q1 | $1.6M | Hold |
5,224
| – | – | 0.09% | 117 |
|
|
2013
Q4 | $1.46M | Sell |
5,224
-4,201
| -45% | -$1.17M | 0.08% | 117 |
|
|
2013
Q3 | $2.27M | Sell |
9,425
-2,425
| -20% | -$584K | 0.14% | 87 |
|
|
2013
Q2 | $2.55M | Buy |
+11,850
| New | +$2.55M | 0.16% | 79 |
|